Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2008
11/25/2008US7455839 Method of inhibiting the formation of inhibin/betaglycan complexes with an anti-betaglycan antibody
11/25/2008US7455835 Administering soluble cytotoxic t-lymphocyte associated antigen (ctla4) molecule that binds a cell surface B7 molecule
11/25/2008CA2375549C Delivery system for biological material
11/25/2008CA2361318C Novel nucleosides and oligonucleotide analogues
11/25/2008CA2345354C Antisense modulation of bcl-x expression
11/25/2008CA2323687C Mutant recombinant allergens
11/25/2008CA2303416C Repressed trans-activator system for characterization of protein-protein interactions
11/25/2008CA2295968C In vitro method for providing templates for dna sequencing
11/25/2008CA2295306C Dna polymerase-related factors
11/25/2008CA2268029C Therapeutic and diagnostic applications of laminin and laminin-derived protein fragments
11/25/2008CA2235771C Rhodosporidium d-amino acid oxidase
11/25/2008CA2223078C Nucleic acid ligands that bind to and inhibit dna polymerases
11/25/2008CA2213697C S-adenosyl-l-homocystein hydrolase promoter
11/25/2008CA1341586C Seed specific transcriptional regulation
11/20/2008WO2008141308A2 Gene expression and pain
11/20/2008WO2008141281A1 A modified secretion system to increase expression of polypeptides in bacteria
11/20/2008WO2008141190A1 Heterologous production of capreomycin and generation of new capreomycin derivatives through metabolic engineering
11/20/2008WO2008141129A1 G-QUARTET OLIGONUCLEOTIDES THAT TARGET HYPOXIA-INDUCIBLE FACTOR 1-α (HIF1 α)
11/20/2008WO2008141096A2 Nucleic acids for inducing expression of transcripts and proteins and methods for making and using them
11/20/2008WO2008140887A1 Nucleotidyltransferases with enhanced nucleotide triphosphate flexibility
11/20/2008WO2008140862A1 Optimization of colicin production
11/20/2008WO2008140610A2 Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast
11/20/2008WO2008140582A2 Production of anti-microbial peptides
11/20/2008WO2008140415A1 H5 subtype-specific binding proteins useful for h5 avian influenza diagnosis and surveillance
11/20/2008WO2008140334A1 Compositions and methods for regulating plant gene expression
11/20/2008WO2008140173A1 Methods for effectively coexpressing il-12 and il-23
11/20/2008WO2008140126A1 Single-stranded cyclic rna, and method for production thereof
11/20/2008WO2008140060A1 Activated protease indicator
11/20/2008WO2008139938A1 Double-stranded nucleic acid molecule targeting for human papilloma virus type-16 gene, and pharmaceutical agent comprising the molecule
11/20/2008WO2008139844A1 Method for producing glucuronic acid by glucuronic acid fermentation
11/20/2008WO2008139627A1 Replication/transcription system for influenza virus genome using yeast cell
11/20/2008WO2008139591A1 Method of producing recombinant aprotinin
11/20/2008WO2008139496A1 Recombinant human insulin and a method thereof
11/20/2008WO2008139334A2 Method for increasing the resistance of a plant to endoparasitic nematodes
11/20/2008WO2008139262A2 Oligoribonucleotides and uses thereof
11/20/2008WO2008139259A2 Fluorescent proteins for monitoring intracellular superoxide production
11/20/2008WO2008139202A1 Neutralizing monoclonal antibody against human dll4
11/20/2008WO2008139153A2 Expression system
11/20/2008WO2008138994A1 Anti-tumor drug, medicament, composition, and use thereof
11/20/2008WO2008138975A1 Yield enhancement in plants by modulation of zmpkt
11/20/2008WO2008138904A2 Rna antagonist compounds for the modulation of her3
11/20/2008WO2008138896A1 A method for sustainable transgene transcription
11/20/2008WO2008138835A1 Expression cloning method suitable for selecting library clones producing a polypeptide of interest
11/20/2008WO2008138658A2 Pharmaceutical compounds comprising abasic oligonucleotides
11/20/2008WO2008138649A2 Signaling peptides
11/20/2008WO2008138648A1 Vectors for multiple gene expression
11/20/2008WO2008138619A2 New ttv sequences for diagnosis, prevention and treatment of childhood leukaemia
11/20/2008WO2008138579A1 Archaeal plasmid vector system
11/20/2008WO2008138577A1 Means for treating inflammatory diseases, autoimmune diseases and cancer
11/20/2008WO2008138533A1 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
11/20/2008WO2008138229A1 Recombinant protein expression system with enhanced yield and immunogenicity
11/20/2008WO2008138189A1 Use of cthrc1 in diagnosing cancer of liver
11/20/2008WO2008138131A1 Bone targeted alkaline phosphatase, kits and methods of use thereof
11/20/2008WO2008138129A1 Thuricin 17 for promoting plant growth and disease resistance and transgenic plants
11/20/2008WO2008138123A1 Screening assay to identify correctors of protein trafficking defects
11/20/2008WO2008138109A1 Pectate lyases with increased thermostability and/or enzymatic activity
11/20/2008WO2008138072A1 Treatment and prevention of influenza
11/20/2008WO2008138066A1 Suppression of viruses involved in respiratory infection or disease
11/20/2008WO2008121563A3 Modified fgf-21 polypeptides and their uses
11/20/2008WO2008121199A3 Transgenic animal models of disease
11/20/2008WO2008118356A3 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
11/20/2008WO2008116220A3 Methods and compositions related to riboswitches that control alternative splicing
11/20/2008WO2008116094A3 Combined hairpin-antisense compositions and methods for modulating expression
11/20/2008WO2008114011A3 Fc polypeptide variants obtained by ribosome display methodology
11/20/2008WO2008112633A3 Method of meristem excision and transformation
11/20/2008WO2008112008A9 Sensor proteins and assay methods
11/20/2008WO2008110848A3 Plant responses
11/20/2008WO2008109551B1 Nucleic acid compounds for inhibiting tacstd1 gene expression and uses thereof
11/20/2008WO2008109544B1 Nucleic acid compounds for inhibiting muc1 gene expression and uses thereof
11/20/2008WO2008109534B1 Nucleic acid compounds for inhibiting ezh2 gene expression and uses thereof
11/20/2008WO2008109500A3 Nucleic acid compounds for inhibiting prkca gene expression and uses thereof
11/20/2008WO2008109492B1 Nucleic acid compounds for inhibiting igf1r gene expression and uses thereof
11/20/2008WO2008109472A3 Nucleic acid compounds for inhibiting pcsk9 gene exprression and uses thereof
11/20/2008WO2008109450A3 Nucleic acid compounds for inhibiting id-1 gene expression and uses thereof
11/20/2008WO2008109382B1 Nucleic acid compounds for inhibiting pkn3 gene expression and uses thereof
11/20/2008WO2008109379B1 Nucleic acid compounds for inhibiting il17a gene expression and uses thereof
11/20/2008WO2008109377B1 Nucleic acid compounds for inhibiting vegf family gene expression and uses thereof
11/20/2008WO2008109376B1 Nucleic acid compounds for inhibiting bcr-abl gene expression and uses thereof
11/20/2008WO2008109356B1 Nucleic acid compounds for inhibiting tnfsf13b gene expression and uses thereof
11/20/2008WO2008106644A3 Treatment of diseases characterized by inflammation
11/20/2008WO2008100789A8 Compositions and methods for altering elastogenesis
11/20/2008WO2008100749A3 Transfection in magnetically driven continuous flow
11/20/2008WO2008098183A3 Combination therapy for treating cancer
11/20/2008WO2008097854A3 Method and substances for treating hpv infection
11/20/2008WO2008094986A3 Bacterial leader sequences for increased expression
11/20/2008WO2008093280A3 Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen
11/20/2008WO2008092153A3 Modification of exosomal components for use as a vaccine
11/20/2008WO2008088863A9 Stem cell gene targeting
11/20/2008WO2008083271A3 Methods and compositions for enhanced protein expression and purification
11/20/2008WO2008083198A3 Genetic markers for orobanche resistance in sunflower
11/20/2008WO2008082726A8 Real time monitoring of microbial enzymatic pathways
11/20/2008WO2008078102A3 Lipids and their use as non-viral delivery vehicle
11/20/2008WO2008076987A3 Genes encoding fatty acid desaturases from sorghum bicolor
11/20/2008WO2008076290A3 Optimized non-canonical zinc finger proteins
11/20/2008WO2008074839A3 Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
11/20/2008WO2008070344A3 Compositions and methods for binding sphingosine-1-phosphate
11/20/2008WO2008070179A3 Genes and uses for plant improvement
11/20/2008WO2008067408A3 Method of isolating and propagating stem cells from benign tumors
11/20/2008WO2008063340A3 Delta-8 desaturases and their use in making polyunsaturated fatty acids
11/20/2008WO2008057537A3 System and method for identifying erythropoietin-responsive genes
1 ... 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 ... 4023